• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH INC. BINAX NOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH INC. BINAX NOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195-000
Device Problem Use of Device Problem (1670)
Patient Problems Blurred Vision (2137); Burning Sensation (2146)
Event Date 12/28/2020
Event Type  Injury  
Manufacturer Narrative
No additional information, evaluation or clarification of data is applicable.The reported event in nature and severity for binaxnow covid-19 ag card are captured within the product's risk management file.No further action is required.
 
Event Description
A customer reported accidentally using the binaxnow covid-19 ag extraction reagent solution in their eye on (b)(6) 2020.The customer reported that he had slightly blurry vision and burning in the eye on the day of the event.The customer had an eye exam on (b)(6) 2020, where his physician provided tobradex eyedrops for the mild irritation.The customer was to have a follow-up session with the physician and was advised to inform if the issue did not resolve.There has been no additional communication from the customer.The customer was provided with the safety data sheet for the binaxnow covid-19 ag card reagent solution.No additional information has been provided.The extraction reagent packaged in this kit contains saline, detergents and sodium azide, preservatives that will inactivate cells and virus particles.Samples eluted in this solution are not suitable for culture.Although the volume is too low to likely cause serious adverse events, due to the ingredients of the reagent and the sensitive nature of the eye, there is moderate risk of serious injury to the eye.Therefore, the incident shall be considered reportable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAX NOW COVID-19 AG CARD
Type of Device
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
alexa wakley
10 southgate road
scarborough, ME 04074
2077305750
MDR Report Key11219361
MDR Text Key230926423
Report Number1221359-2021-00195
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA202537
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 01/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue Number195-000
Initial Date Manufacturer Received 12/28/2020
Initial Date FDA Received01/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-